Target Price | $2.04 |
Price | $0.81 |
Potential |
152.10%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target BIO-key International, Inc. 2026 .
The average BIO-key International, Inc. target price is $2.04.
This is
152.10%
register free of charge
$2.10
159.52%
register free of charge
$2.02
149.63%
register free of charge
|
|
A rating was issued by 7 analysts: 6 Analysts recommend BIO-key International, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the BIO-key International, Inc. stock has an average upside potential 2026 of
152.10%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 6.93 | 7.45 |
10.58% | 7.45% | |
Net Margin | -62.05% | -43.77% |
43.56% | 29.46% |
3 Analysts have issued a sales forecast BIO-key International, Inc. 2025 . The average BIO-key International, Inc. sales estimate is
This results in the following potential growth metrics:
3 BIO-key International, Inc. Analysts have issued a net profit forecast 2025. The average BIO-key International, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.09 | -0.56 |
86.26% | 73.21% | |
P/E | negative | |
EV/Sales | 0.45 |
3 Analysts have issued a BIO-key International, Inc. forecast for earnings per share. The average BIO-key International, Inc. EPS is
This results in the following potential growth metrics and future valuations:
BIO-key International, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.